Clinical Trial Update: An Open Label Safety Study of Tipranavir Co-administered With Low-dose Ritonavir in Patients With Advanced HIV-1 Infection and Limited Treatment Options.

View source ↗

Summary

An open-label safety study of tipranavir boosted with low-dose ritonavir in advanced HIV-1 infection with limited treatment options, with marketing approval gra…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• Ritonavir (Ritonavir)
• Tipranavir (tipranavir)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: HIV Infections | Status: APPROVED_FOR_MARKETING